Matching an infection with Candida auris, a pathogenic yeast, to an effective antifungal is a critical clinical decision. That decision relies on susceptibility testing, but commercially available ...
A recent study published in the journal Biomedicines aimed to determine the antifungal tolerance of Candida auris (C. auris) to all three classes of antifungal drugs commonly used to treat invasive ...
Morning Overview on MSN
How a common fungus outsmarts top drugs and our immune defenses?
Fungal pathogens that live harmlessly on and inside the human body are increasingly defeating the limited arsenal of antifungal drugs, while simultaneously dodging the immune system’s surveillance.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results